Comments to CFDA on the Provision on Medical Device Adverse Events Monitoring and Re-evaluation

2015-12-18 | Beijing

Members have quite a few concerns regarding this regulation in drafting. Comments collected and consolidated are concrete in total 18 pages. While the chamber-COCIR jointly submitted the comments to National Center for ADR Monitoring, CFDA, we also requested a face to face meeting with them.